Yes, COVID-19 can suppress your immune system in several ways, both during the infection and for months afterward. The virus directly attacks key immune cells, disrupts the production of new ones, and interferes with your body’s early warning system against pathogens. For most people who have mild infections, immune function recovers over time. But for some, particularly those who develop long COVID, immune dysfunction can persist for eight months or longer.
How the Virus Attacks Immune Cells Directly
SARS-CoV-2 doesn’t just infect your lungs. It also targets T cells, the white blood cells responsible for identifying and killing infected cells throughout your body. Research published in Nature found that the virus can infect both helper T cells (which coordinate your immune response) and killer T cells (which destroy infected cells), causing them to self-destruct. In some hospitalized patients, T-cell counts dropped to near zero while other immune cells like B cells and natural killer cells remained relatively unaffected.
This selective destruction of T cells creates a gap in your defenses. Helper T cells, in particular, act as the immune system’s command center. When they die off in large numbers, it can trigger a cascade of excessive inflammation that damages healthy tissue while simultaneously leaving you less equipped to fight off the original infection or new ones.
The Virus Sabotages Your First Line of Defense
Before T cells even get involved, your body relies on a faster, more general defense system called the innate immune response. One of its most important tools is a group of signaling molecules called interferons, which act as an alarm system, warning neighboring cells that a virus is present and triggering protective measures.
SARS-CoV-2 is remarkably good at silencing this alarm. The virus carries multiple proteins that block interferon production at several different points, and it actually suppresses interferons even more effectively than the original SARS virus from 2003. One viral protein, ORF3b, is a shorter version of its counterpart in SARS-CoV but suppresses interferon signaling more efficiently. Another viral enzyme cuts up pieces of the virus’s own genetic material to avoid detection. The result is that the virus replicates aggressively in your lungs before your immune system fully recognizes the threat, giving it a head start that shapes the entire course of the infection.
Effects on Immune Cell Production
Your bone marrow is the factory where new immune cells are made, and COVID-19 disrupts this factory too. Research in Experimental & Molecular Medicine found that the virus affects the stem cells in bone marrow that give rise to all blood and immune cells. After infection, these stem cells shift toward producing more of one type of immune cell (myeloid cells, which drive inflammation) at the expense of others. Autopsies of people who died from COVID revealed bone marrow that was overactive but producing the wrong mix of cells, with a severe loss of B cells, the immune cells responsible for making antibodies.
This imbalance means your body may churn out inflammatory cells while falling short on the cells it needs for precise, targeted immune responses. It’s not simply that you have fewer immune cells. The composition of your immune system changes in ways that favor inflammation over effective defense.
Increased Risk of Secondary Infections
The practical consequence of this immune suppression is a higher vulnerability to other infections. During severe COVID-19, many patients developed dangerous bacterial and fungal “superinfections” that took hold while their immune defenses were compromised. The most common fungal infections included aspergillosis, invasive candidiasis, and mucormycosis. Antibiotic use was widespread, prescribed to over 93% of patients even with mild COVID, reflecting the real concern about opportunistic bacteria.
This vulnerability extends beyond the hospital. A large study examining over 29 million medical visits for young children found that prior COVID-19 infection increased the risk of bronchiolitis (most commonly caused by RSV) in 2021 and 2022. The researchers concluded that COVID had lasting adverse effects on both the innate and adaptive immune systems of children, making them more susceptible to severe respiratory infections from other viruses. This finding aligns with the surge in RSV hospitalizations among young children that pediatricians observed in the years following the pandemic’s onset.
How Long Immune Dysfunction Lasts
For people who recover fully from COVID, immune function generally normalizes within weeks to a few months. But for those who develop long COVID, the picture is different. A 2025 study in Nature Immunology found that people with long COVID showed persistent immune activation, chronic inflammation, and T-cell exhaustion for more than 180 days after their initial infection. An independent analysis confirmed that immunological dysfunction persists for at least eight months following even mild-to-moderate infections.
The specific problems researchers identified include overactive inflammatory signaling pathways, disrupted cellular metabolism, and T cells stuck in an “exhausted” state where they remain alive but can no longer function effectively. Some people with long COVID also develop autoantibodies, immune proteins that mistakenly attack the body’s own tissues. A systematic review in The Lancet Infectious Diseases identified several types of autoantibodies associated with long COVID, including ones targeting cell-signaling receptors and proteins involved in cholesterol transport. These autoantibodies may help explain why some long COVID symptoms resemble autoimmune conditions.
There’s also evidence that SARS-CoV-2 genetic material can linger in organs long after the acute infection clears. This viral persistence, along with the possible reactivation of other dormant viruses like Epstein-Barr virus, may keep the immune system in a state of chronic low-grade activation that prevents it from returning to normal.
Vaccination Reduces the Immune Damage
Vaccination before infection significantly blunts the immune disruption COVID causes. Vaccinated people tend to have more regulated immune responses during acute infection, with lower rates of the inflammatory storms and autoantibody formation that drive long-term immune problems. A study of over 500,000 adults found that long COVID risk dropped by 21% after one vaccine dose, 59% after two doses, and 73% after three or more doses compared to unvaccinated individuals.
The downstream effects are substantial. In one study comparing vaccinated and unvaccinated hospitalized COVID patients, major physical symptoms at 12 and 18 months post-infection were present in 52% of vaccinated patients versus nearly 92% of unvaccinated patients. Neuropsychological symptoms showed an even starker difference: 24% versus almost 94%. Vaccinated individuals also had shorter symptom durations and fewer symptoms tied to excessive inflammation, such as headaches, joint pain, and blood pressure instability. The milder acute illness in vaccinated people translates to less tissue damage and, consequently, less immune system disruption to recover from.